Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedResults posting date (Results First Posted 2025-12-12) and enrollment (185) were added, along with a list of participating locations. The page now includes detailed outcome measures and their timeframes (ORR, DOR, DCR, PFS, OS).SummaryDifference5%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision label updated: added 'Revision: v3.3.2' and removed 'Revision: v3.2.0'.SummaryDifference0.0%

- Check37 days agoChange DetectedRemoved the government funding notice that warned about potential delays and unprocessed transactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedObserved changes are limited to UI updates and an updated last-updated timestamp; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange Detected- Added a government funding notice and operating status information for NIH Clinical Center, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check89 days agoChange DetectedPage now shows that results have been submitted and updates the revision to v3.1.0, replacing the previous state (No Results Posted, revision v3.0.2).SummaryDifference0.2%

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.